(Q70671888)
Statements
Randomized phase II trial of high-dose interleukin-2 either alone or in combination with interferon alfa-2b in advanced renal cell carcinoma (English)
M B Atkins
J Sparano
R I Fisher
G R Weiss
K A Margolin
K I Fink
L Rubinstein
A Louie
J W Mier